coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Hwl Network PCN, Bolton (LAD) · Health Inequalities Profile

    PCN U05517 · NHS Greater Manchester Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    27,096

    Registered population

    62.5% aged 18–64

    14.2%

    Aged 65+

    ICB 14.9% · England 17.9%

    46.4%

    Ethnic minority (non-White)

    35.2% Asian · England 9.6%

    74.1%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~14,925

    Core20 residents (est.)

    Resident basis; registered basis ~22,073 · see page 3

    3,461

    Hypertension register

    +0.98% in 3 yrs · England +5.60%

    372

    SMI register

    10.3% of Bolton (LAD)'s

    702

    COPD register

    Reviews -13.43% in 3 yrs

    Forecast to 2030

    3,620

    Hypertension patients, 2030

    +159 on today

    63.7%

    QRISK ≥20% on statins, 2030

    +0.06pp over 3 yrs

    3.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -13.4%
    COPD and heart failure reviews fell sharply.

    Over 2023 to 2025, COPD reviews fell 13.4% to 67.0% (England +2.8%) and heart failure reviews fell 10.5% to 74.8% (England +8.7%).

    52.4%
    Cervical screening at ages 25-49 lags England.

    Coverage is 52.4%, trailing Bolton (LAD) (63.9%) and England (66.8%) by 14.5 pp after falling 8.1% over 2023 to 2025 (England -1.0%).

    +6.6 pp
    Mental health checks and breast screening rose.

    Over 2023 to 2025, mental health register blood pressure checks rose +6.6 pp to 80.5% (England +4.4 pp); breast screening rose +9.3% to 67.7%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Younger age structure and 35.2% Asian ethnicity may shape local service demand

    HWL NETWORK PCN serves 27,096 registered patients. Children aged 0-17 comprise 23.3% of the list, below Bolton (23.7%) by 0.4 pp but above the ICB (21.8%) and England (19.6%). Patients aged 65+ account for 14.2%, below Bolton (14.7%), the ICB (14.9%) and England (17.9%). In associated resident areas, Census data shows 35.2% Asian or Asian British residents, exceeding Bolton (20.1%), the ICB (13.6%) and England (9.6%), alongside 53.6% White residents. Age profiles reflect registered patients, whereas ethnicity measures Census usual residents in associated areas.

    Age profile

    0–1723.3%
    18–6462.5%
    65+14.2%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White53.6%
    Asian35.2%
    Black5.9%
    Other2.9%
    Mixed2.3%

    Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bolton LA)1,9232,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)51.3%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bolton LA)9581,0219552024/25
    Falls deaths, all ages, per 100,000 (Bolton LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 74.1% PCN-wide but spans 60.5 pp between member practices

    Core20 deprivation reaches 74.1% of registered patients across the PCN, exceeding Bolton (LAD) (47.8%), NHS Greater Manchester Integrated Care Board (40.7%), and England (21.0%). Average IMD decile is 2.8 (England 5.5). Across captured practices, Core20 shares span a 60.5 pp range. Burnside Surgery records 39.5%, whereas Octagon Medical Centre records 100.0%. Practice-level estimates sum to 22,073 registered patients compared with a PCN resident estimate of 14,925, indicating denominator differences that require reconciliation before targeting.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Octagon100.0% · 6,076 patients
    Halliwell 293.8% · 3,303 patients
    Halliwell 390.9% · 4,673 patients
    Charlotte Street79.1% · 1,798 patients
    Dr Rizwan And Dr78.3% · 4,519 patients
    Burnside39.5% · 1,704 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    372

    SMI register

    1.36% recorded prevalence

    190

    Learning disability register

    0.70% recorded prevalence

    15

    Care homes, 281 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Bolton (LAD), Census 2021

    The PCN records 372 severe mental illness patients (1.4% prevalence, above Bolton's 1.1%, the ICB's 1.1% and England's 1.0%) and 190 learning disability patients (0.7%, above Bolton, the ICB and England at 0.6%). Catchment data lists 281 care home beds across 15 sites, though occupancy is unconfirmed.

    Severe mental illness: physical health checks

    SMI prevalence is 1.4% (England 1.0%). Recorded blood pressure checks reached 80.5% (England 83.4%) and BMI was 79.3% (England 82.1%). Checks trail national benchmarks, which may reflect recall gaps, unverified locally; audits would test this.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    3,461

    Hypertension register

    +0.98%

    Register growth, 3 yrs

    Bolton (LAD) +4.70% · England +5.60%

    +1.54pp

    BP control, under 80

    ≤140/90 · +0.24pp aged 80+

    +159

    More patients by 2030

    Forecast 3,620 (12.93%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 12.7% (3,461 patients), below Bolton (14.8%), NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%), with register growth of +1.0% over 2023 to 2025 lagging England (+5.6%). This yields an unadjusted register gap of +537 to +666 patients, though this is not age-adjusted for a younger population (14.2% aged 65+ versus 17.9% in England). Among recorded patients, 89.7% had a recent blood pressure check (England 90.0%) and 69.2% are treated to target (England 70.3%). Lower recorded prevalence may reflect age structure or under-detection, unverified locally; case-finding audits would test this.

    Lipids and statins

    QRISK ≥ 20% lipid therapy is 63.6%, matching England (63.6%) but trailing NHS Greater Manchester Integrated Care Board (67.0%), with change of +0.1% over 2023 to 2025 lagging England (+6.2%). Primary diabetes statin therapy is 71.6% (England 73.2%). Trailing the ICB may indicate variation in statin initiation, unverified locally; structured reviews would test this.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202648,008£1.40£1.94£1.86£67,211
    Cardiovascular (all), 202566,485£2.90£3.15£3.33£192,806

    For lipid-regulating drugs in 2026, the PCN prescribed 48,008 items at £1.40 per item, below Bolton (£1.81), NHS Greater Manchester Integrated Care Board (£1.94) and England (£1.86). Across 48,008 items, this is £22,084 less than at England's unit cost. This unit-cost indicator does not reflect efficiency, treatment appropriateness or formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −3.72%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −6.11%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.6% (702 patients), but reviews fell 13.4% over 2023 to 2025 to 67.0% (England +2.8% to 76.4%). Asthma prevalence is 6.4% (1,619 patients), with reviews down 3.7% over 2023 to 2025 (England +4.4%) to 65.6%, leaving about 560 unreviewed. Concurrently, youth asthma prescribing reached 2,284 items per 1,000 (England 1,488) and second-hand smoke recording was 70.5% (England 78.8%). Heavy prescribing alongside falling reviews may reflect unreviewed symptom burden, unverified locally; record audits would test this.

    Cancer register and children's immunisation

    Cancer recorded prevalence is 2.9% (781 patients; England 3.8%). In Q1 2025/26, 12-month 6-in-1 coverage was 86.8% (England 91.0%), below the 95.0% target by 8.2 pp. By age 5, MMR1 reached 96.9% and MMR2 92.8% (a 4.1 pp difference). Early infant vaccination lags before catching up, which could reflect early access friction, unverified locally; outreach audits would test this.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months86.8%

    England 91.0%

    6-in-1 complete primary course at 24 months93.7%

    England 92.2%

    MMR dose 1 at 24 months88.9%

    England 88.3%

    MMR dose 2 at age 592.8%

    England 82.8%

    4-in-1 pre-school booster at age 588.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of staged cancers across NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (England 55.3%), showing a distance of -19.4 pp to the 75.0% national ambition by 2028, representing about 2,270 extra early-stage cases. Known-stage share was 70.8% (England 67.0%). Wider early detection links with primary care screening: PCN cervical screening coverage for women aged 25-49 is 52.4% (England 66.8%, Bolton 63.9%), after falling 8.1% over 2023 to 2025 (England -1.0%). Lower cervical screening uptake across the network could delay early detection, making proactive recall an operational priority.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data, Bolton NHS Foundation Trust met the 28-day faster diagnosis standard at 80.5% (ICB 79.5%, England 79.3%) and the 31-day standard at 96.5% (ICB 96.5%, England 92.5%). On 62-day treatment, Bolton NHS Foundation Trust reached 69.7%, a distance of -15.3 pp to the 85.0% standard (Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust 76.8%, Northern Care Alliance NHS Foundation Trust 78.6%, ICB 75.7%, England 71.2%). For diagnostics, 25.3% of cystoscopy patients waited 6+ weeks at Bolton NHS Foundation Trust (England 24.4%), while MRI waits were 2.0%.

    Pathways within standard (%)BoltonNorthern Care AllianceWrightington, Wigan and LeighGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4875.2082.8079.5379.32
    31-day treatment (96%)96.5094.5489.0496.4992.50
    62-day referral to treatment (85%)69.6678.6576.7875.7371.16
    Diagnostic waits over 6 weeks (%)BoltonNorthern Care AllianceWrightington, Wigan and LeighEngland
    MRI2.055.090.4921.40
    CT19.404.107.789.92
    Echocardiography3.4831.4824.3728.48
    Colonoscopy1.3340.046.1030.83
    Gastroscopy2.0636.4812.5429.02
    All 15 DM01 tests15.7815.7114.3623.14
    Community services activityBolton residentsGreater Manchester ICB
    Care contacts49,315573,310
    Referrals4,07594,470
    Patients with a contact17,765183,535

    Community services (residents of Bolton), Jun 2026 (provisional). In provisional June 2026 data, 51.6% of community service contacts for Bolton borough residents were with adults aged 65 and over (25,460 of 49,315 contacts). This caseload reflects borough-level activity rather than PCN provision, indicating substantial older-age community service demand.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 22.9 pp across practices while vaccination achievement spans 56.9 pp

    In 2025/26, clinical QOF achievement reached 100.0% at Dr Rizwan And Dr Awan, yet vaccination and immunisation achievement spanned 56.9 pp, from 15.6% at Dr Rizwan And Dr Awan to 72.6% at Charlotte Street Surgery. Personalised care adjustment rates spanned from 4.9% at Burnside Surgery to 15.2% at Octagon Medical Centre (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Halliwell 210593.890.3%91.0%87.1%
    Burnside Surgery12439.574.7%68.0%86.5%
    Dr Rizwan And Dr9378.389.2%82.6%84.8%
    Octagon91100.073.9%74.7%81.4%
    Halliwell 39890.987.3%78.4%81.0%
    Charlotte Street7779.167.4%85.6%71.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBolton (LAD)AssetPCNBolton (LAD)
    Care homes (catchment)15 (281 beds)n/aSchools (catchment)48n/a
    Children's centres318Places of worship37144
    Libraries17Primary schools (LA maintained)1261
    Primary academies432Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and COPD review recall

    Asthma reviews fell 3.7% over 2023 to 2025 (England +4.4%) to 65.6% of 1,619 patients (about 560 unreviewed); COPD reviews fell 13.4% to 67.0% of 702 (England 76.4%). For discussion: run single-template asthma and COPD recall with after-school slots and inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Targeted Core20 hypertension case-finding

    Recorded hypertension is 12.7% (3,461 patients) versus 14.8% in Bolton and 15.2% in England (+1.0% three-year growth versus England +5.6%), an unadjusted gap of +537 to +666. For discussion: audit uncoded raised blood pressure readings and run opportunistic checks in high-Core20 practices. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Cervical screening recall and access recovery

    Cervical screening at ages 25-49 is 52.4%, below Bolton (63.9%) by 11.5 pp, the ICB (65.9%) by 13.5 pp, and England (66.8%) by 14.5 pp after falling 8.1% over 2023 to 2025 (England -1.0%). For discussion: follow up non-responders with adapted reminders, telephone outreach, and evening or weekend screening slots. Moderate effort to run.

    Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.

    Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Core deprivation list reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Infant immunisation recall outreach (p6)6-in-1 coverage at 12 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall recovery (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and patient access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma and COPD review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Targeted Core20 hypertension case-finding (p12)Hypertension register · Hypertension: QOF prevalence · Aged 65+Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Cervical screening recall and access recovery (p12)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) · Core20 cohort (IMD quintile 1) · Asian / Asian BritishFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15